Warby Parker Inc.
NYSE:WRBYMedical - Instruments & Supplies
+$0.92 today
- Market cap
- $3.07B
- Beta
- 1.97
- P/E (TTM)
- 2305.1
- EPS (TTM)
- $0.01
Volume 5.90M
Average 2.81M
WRBY Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Warby Parker Inc.NYSE: WRBY
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization growth accelerates
Q2 FY2026 depreciation & amortization of $14.07M rose 12.7% year over year, ahead of the +9.5% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 2.2% from the prior quarter. Over 3 fiscal years it compounded at +16.4% a year.
Context
- Depreciation & amortization amounted to 5.8% of revenue in FY2025, down 0.2 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +12.7% holds above the trailing-twelve-month pace of +9.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 50.28M USD
- Year-over-year change
- +9.6%
- 4-year CAGR
- +23.1%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 50.28M | +9.6% |
| FY2024 | 2024-12-31 | 45.87M | +19.0% |
| FY2023 | 2023-12-31 | 38.55M | +21.0% |
| FY2022 | 2022-12-31 | 31.86M | +45.7% |
| FY2021 | 2021-12-31 | 21.87M | — |
Depreciation & Amortization vs competitors
How WRBY compares with its peers on the latest reported figures
- WRBY's LTM Jun 2026 depreciation & amortization of $53.47M is the 8th largest of the 10 companies compared; the peer median is $138.1M.
- Its year-over-year change of +9.5% is the 3rd highest of 10, against a peer median of +1.2%.
- Depreciation & amortization amounts to 5.9% of revenue for WRBY, versus a peer median of 9.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.17B | -5.6% | -4.7% | 10.8% | |
| LTM Mar 2026 | $447.8M | +0.5% | +15.9% | 16.9% | |
| LTM Mar 2026 | $353M | +3.2% | +2.4% | 9.6% | |
| LTM Jun 2026 | $204.78M | -1.5% | -5.1% | 9.5% | |
| LTM Jul 2026 | $138.1M | +15.3% | +12.4% | 7.5% | |
| LTM Jun 2026 | $110.07M | -4.5% | +6.2% | 8.1% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $79.99M | +12.4% | +1.0% | 3.4% |
| LTM Jun 2026 | $53.47M | +9.5% | +16.4% | 5.9% | |
| LTM Jun 2026 | $22.24M | +1.2% | +16.4% | 14.3% | |
| LTM Mar 2026 | $10.49M | +6.6% | +3.4% | 4.1% | |
| Peer median (excluding WRBY) | $138.1M | +1.2% | +3.4% | 9.5% | |
Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (144.27M) | (110.39M) | (63.2M) | (20.39M) | 1.64M |
| Depreciation & Amortization | 21.87M | 31.86M | 38.55M | 45.87M | 50.28M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 107.15M | 98.03M | 70.51M | 47.29M | 34.54M |
| Change in Working Capital | (24.5M) | (14.55M) | 5.81M | 19.26M | 17.55M |
| Accounts Receivables | (392K) | (451K) | (345K) | (169K) | (1.34M) |
| Inventory | (18.62M) | (11.79M) | 6.61M | 9.89M | 7.83M |
| Accounts Payables | (11.11M) | (7.94M) | 1.63M | 689K | 8.5M |
| Other Working Capital | 5.63M | 5.64M | (2.09M) | 8.85M | 2.55M |
| Other Non-Cash Items | 7.76M | 5.42M | 9.32M | 6.72M | 6.78M |
| Operating Cash Flow | (31.99M) | 10.37M | 60.99M | 98.74M | 110.79M |
| Capital Expenditures | (48.51M) | (60.18M) | (53.67M) | (64.03M) | (67.05M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (1M) | (2M) | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (48.51M) | (60.18M) | (54.67M) | (66.03M) | (67.05M) |
| Debt Repayment | 31.61M | 91K | 0 | 0 | 0 |
| Common Stock Issued | 20.04M | 3.2M | 2.87M | 4.63M | 2.36M |
| Common Stock Repurchased | (8.09M) | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (20.56M) | 0 | 0 | 333K | (14.36M) |
| Financing Cash Flow | 23M | 3.29M | 2.87M | 4.96M | (12M) |
| Effect of Forex Changes | (161K) | (1.31M) | (882K) | (406K) | 457K |
| Net Change in Cash | (57.67M) | (47.83M) | 8.31M | 37.27M | 32.2M |
| Free Cash Flow | (80.51M) | (49.81M) | 7.32M | 34.71M | 43.74M |
Warby Parker Inc.
NYSE:WRBY
Intrinsic Alpha fair value
Locked
Current Price
$28.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.